A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

FDA recognizes uncertainty in COVID-19 booster efficacy; Invivyd plans innovative monoclonal antibody development for prevention and treatment.

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use of two Covid-19 vaccines, newly released documents show.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Six major medical groups, and a pregnant physician, are suing HHS Secretary Robert F. Kennedy Jr. over changes he made to ...

FDA grants full approval to Moderna's COVID-19 vaccine for children aged 6 months to 11 years with medical vulnerabilities, ...